Hi armiston,
I'm on arm G, HT plus Abiraterone.
I've been on it for around a year and a half, the trial should finish for me this summer.
I can't say I've had any negative experiences while being on this arm beyond the standard HT type stuff.
I can say I've had positive experiences though.
Being a bit of a geek I found a PCa app for my iPad. Amongst other things it allows you to map your PSA results and display them on a graph.
I first started HT and then the abiraterone was added after all the formalities were sorted, so I had some time on HT only before hitting the trial.
The big thing I noticed was that being on HT mapped a definable curve (happily downwards) but once I had the abiraterone in my system the graph took a distinct trajectory downwards again defining a new mappable curve.
I soon hit the bottom and I'm happy to say I'm ploughing a furrow all along the bottom for some time now.
So, I'd say abiraterone hit the PCa separately and in addition to HT, with beneficial results.
As to survival times? Who knows.
I presented with a PSA of around 500 at diagnosis.
I was given a prognosis of three years. (That statement is a can of worms to be discussed elsewhere)
I'm at around the two year mark and my PSA has sat at 0.01 for a while now.
I think I'll be still be pre mets at my three year mark judging at my current performance, fingers crossed.
As mentioned, my two trial years will be up in the summer, I'll be back to HT only.
I'll be interested to see what happens without the abiraterone input.
In the meantime I've also had RT so that also needs to be added to the mix...
What I have is MY PCa, what you have is YOUR PCa.
The journey is likely to have differences, there are so many factors to consider beyond just the treatment.
I take heart from the old campaigners on here, some hitting over ten years and still living life to the full.
All the best
Kevin